Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions - Wubben, Thomas J.; Johnson, Mark W.; Sohn, Elliott H.; Peairs, James J.; Kay, Christine N.; Kim, Stephen J.; Gardner, Thomas W.; Paulus, Yannis M.; Zacks, David N.; Steinle, Nathan C.; Avery, Robert L.; Berrocal, Maria H. (American journal of ophthalmology, 2019)
Keywords: Adult; Aged; Angiogenesis Inhibitors - administration & dosage; Bevacizumab - administration & dosage; Clinical trials; Diabetes; Diabetic retinopathy; Diabetic Retinopathy - diagnosis; Diabetic Retinopathy - drug therapy; Disease; Disease Progression; Drug Administration Schedule; Female; Fluorescein Angiography - methods; Follow-Up Studies; Fundus Oculi; Glaucoma; Hemoglobin; Hemorrhage; Humans; Intravitreal Injections; Male; Middle Aged; Ophthalmology; Retina - pathology; Retrospective Studies; Tomography, Optical Coherence - methods; Treatment Outcome; Vascular endothelial growth factor; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity; Ann Arbor Michigan